Eliem Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
ANTX
AN2 Therapeutics, Inc. |
$1.18 | $35.61 M | -0.78 | 22 |
IPSC
Century Therapeutics, Inc. |
$0.59 | $50.62 M | -2.18 | 140 |
ACRV
Acrivon Therapeutics, Inc. Common Stock |
$1.20 | $37.78 M | -0.56 | 75 |
AVTE
Aerovate Therapeutics, Inc. |
$2.68 | $77.68 M | -0.05 | 4 |
MNOV
MediciNova, Inc. |
$1.26 | $61.80 M | -5.48 | 13 |
PHVS
Pharvaris N.V. |
$16.56 | $902.41 M | -5.16 | 108 |
PEPG
PepGen Inc. |
$1.40 | $45.65 M | -0.44 | 79 |
PMVP
PMV Pharmaceuticals, Inc. |
$1.10 | $57.15 M | -0.93 | 47 |
CYT
Cyteir Therapeutics, Inc. |
$3.02 | $108.71 M | -3.25 | 46 |
RZLT
Rezolute, Inc. |
$4.14 | $354.05 M | -3.57 | 64 |
ADAG
Adagene Inc. |
$1.92 | $72.36 M | -2.59 | 138 |
ANEB
Anebulo Pharmaceuticals, Inc. |
$1.46 | $59.98 M | -5.84 | 2 |
STTK
Shattuck Labs, Inc. |
$0.99 | $47.42 M | -0.71 | 44 |
HCWB
HCW Biologics Inc. |
$5.05 | $12.19 M | -0.2 | 36 |
CSBR
Champions Oncology, Inc. |
$7.98 | $110.34 M | 17.73 | 210 |
MOLN
Molecular Partners AG |
$3.83 | $141.23 M | -1.84 | 158 |
PRDS
Pardes Biosciences, Inc. |
$2.18 | $135.19 M | -1.7 | 57 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
